Implication of screening for FMR1 and FMR2 gene mutation in individuals with nonspecific mental retardation in Taiwan

Diagnostic Molecular Pathology

Volumn 9, Issue 2, 2000, Pages 75-80

  Tzeng, Ching Cherng ^a   Tzeng, Pei Yu ^a   Sun, H Sunny ^a   Chen, Robert M ^a   Lin, Shio Jean ^a  

^a NATIONAL CHENG KUNG UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Betaine; FMR1; FMR2; Fragile X syndrome; FRAXA; FRAXE; Nonradioactive; Polymerase chain reaction; Screening; Southern blot analysis

Indexed keywords

ARTICLE; FEMALE; FRAGILE X SYNDROME; GENE MUTATION; GENETIC RISK; GENETIC SCREENING; HETEROZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL DEFICIENCY; PREVALENCE; PRIORITY JOURNAL; TAIWAN;

ADOLESCENT; BLOTTING, SOUTHERN; CHILD; DNA; DNA MUTATIONAL ANALYSIS; FEMALE; FRAGILE X MENTAL RETARDATION PROTEIN; FRAGILE X SYNDROME; GENETIC SCREENING; HUMANS; MALE; MENTAL RETARDATION; MUTATION; NERVE TISSUE PROTEINS; NUCLEAR PROTEINS; POLYMERASE CHAIN REACTION; PROTEINS; RNA-BINDING PROTEINS; TAIWAN; TRANS-ACTIVATORS;

EID: 0034081385     PISSN: 10529551     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019606-200006000-00002     Document Type: Article

References (34)

1. Arvio M, Peippo M, Simola KO. Applicability of a checklist for clinical screening of the fragile X syndrome. Clin Genet 1997;52: 211-5.
2. Ashley CT Jr, Wilkinson KD, Reines D, Warren ST. FMR1 protein: conserved RNP family domains and selective RNA binding. Science 1993;262:563-6.
3. Chan SY, Wong V. DNA diagnosis of FRAXA and FRAXE in Chinese children with neurodevelopmental disorders and fragile X syndrome. Clin Genet 1998;53:179-83.
4. Chong SS, Eichler EE, Nelson DL, Hughes MR. Robust amplification and ethidium-visible detection of the fragile X syndrome CGG repeat using Pfu polymerase. Am J Med Genet 1994;51: 522-6.
5. Condorelli DF, Milana G, Dell'Albani P, Roccazzello AM, Insirello E, Pavone L, Mollica F. Routine clinical application of the FRAXA Pfu PCR assay: limits and utility. Clin Genet 1996;50: 366-71.
6. Crawford DC, Meadows KL, Newman JL, et al. Prevalence and phenotype consequence of FRAXA and FRAXE alleles in a large, ethnically diverse, special education-needs population. Am J Hum Genet 1999;64:495-507.
7. El-Aleem AA, Böhm I, Temtamy S, El-Awady M, Awadalla M, Schmidtke J, Stuhrmann M. Direct molecular analysis of the fragile X syndrome in a sample of Egyptian and German patients using non-radioactive PCR and Southern blot followed by chemiluminescent detection. Hum Genet 1995;96:577-84.
8. Flynn GA, Hirst MC, Knight SJ, et al. Identification of the FRAXE fragile site in two families ascertained for X linked mental retardation. J Med Genet 1993;30:97-100.
9. Fu YH, Kuhl DPA, Pizzuti A, et al. Variation of the CGG repeats at the fragile X site results in genetic instability: resolution of the Sherman paradox. Cell 1991;67:1047-58.
10. Giangreco CA, Steele MW, Aston CE, Cummins JH, Wenger SL. A simplified six-item checklist for screening for fragile X syndrome in the pediatric population. J Pediatr 1996;129:611-4.
11. Henke W, Herdel K, Jung K, Schnorr D, Loening SA. Betaine improves the PCR amplification of GC-rich DNA sequences. Nucl Acid Res 1997;25:3957-8.
12. Hirst MC, Barnicoat A, Flynn G, et al. The identification of a third fragile site, FRAXF, in Xq27-q28 distal to both FRAXA and FRAXE. Hum Mol Genet 1993;2:197-200.
13. Hong CJ, Song HL, Lai HC, Tsai SJ, Hsiao KJ. Methanol/acetone treatment helps the amplification of FMR1 CGG repeat fragment in dried blood spots from Guthrie cards. Lancet 1999;353:1153-4.
14. Hou JW, Wang TR, Chuang SM. An epidemiological and etiological study of children with intellectual disability in Taiwan. J Intellect Disabil Res 1998;42:137-43.
15. Knight SJ, Flannery AV, Hirst MC, et al. Trinucleotide repeat amplification and hypermethylation of a CpG island in FRAXE mental retardation. Cell 1993;74:127-34.
16. Knight SJ, Ritchie RJ, Chakrabarti L, et al. A study of FRAXE in mentally retarded individuals referred for fragile X syndrome (FRAXA) testing in the United Kingdom. Am J Hum Genet 1996; 58:906-13.
17. Li SY, Tsai CC, Chou MY, Lin JK. A cytogenetic study of mentally retarded school children in Taiwan with special reference to the fragile X chromosome. Hum Genet 1988;79:292-6.
18. Mazzocco MM, Sonna NL, Teisl JT, Pinit A, Shapiro BK, Shah N, Reiss AL. The FMR1 and FMR2 mutations are not common etiologies of academic difficulty among school-age children. J Dev Behav Pediatr 1997;18:392-8.
19. Meijer H, de Graaff E, Merckx DM, et al. A deletion of 1.6 kb proximal to the CGG repeat of the FMR1 gene causes the clinical phenotype of the fragile X syndrome. Hum Mol Genet 1994;3:615-20.
20. Mila M, Castellvi-Bel S, Sanchez A, Lazaro C, Villa M, Estivill X. Mosaicism for the fragile X syndrome full mutation and deletions within the CGG repeat of the FMR1 gene. J Med Genet 1996;33: 338-40.
21. Mila M, Sanchez A, Badenas C, et al. Screening for FMR1 and FMR2 mutations in 222 individuals from Spanish special schools: identification of a case of FRAXE-associated mental retardation. Hum Genet 1997;100:503-7.
22. Oberle I, Rousseau F, Heitz D, et al. Instability of a 550-base pair DNA segment and abnormal methylation in fragile X syndrome. Science 1991;252:1097-102.
23. Orrico A, Galli L, Dotti MT, Plewnia K, Censini S, Federico A. Mosaicism for full mutation and normal-sized allele of the FMR1 gene: a new case. Am J Med Genet 1998;78:341-4.
24. Pieretti M, Zhang F, Fu Y, Warren ST, Oostra BA, Caskey CT, Nelson DL. Absence of expression of the FMR-1 gene in fragile X syndrome. Cell 1991;66:817-22.
25. Rousseau F, Rehel R, Rouillard P, DeGranpre P, Khandjian EW. High throughput and economical mutation detection and RFLP analysis using a minimethod for DNA preparation from whole blood and acrylamide gel electrophoresis. Hum Mutat 1994;4: 51-4.
26. Rousseau F, Heitz D, Tarleton J, et al. A multicenter study on genotype-phenotype correlations in fragile X syndrome, using direct diagnosis with probe StB12.3: the first 2,253 cases. Am J Hum Genet 1994;57:1006-28.
27. Rousseau F, Rouillard P, Morel ML, Khandjian EW, Morgan K. Prevalence of carriers of premutation-size alleles of the FMR1 gene - and implications for the population genetics of the fragile X syndrome. Am J Hum Genet 1995;57:1006-18.
28. Ryynanen M, Heinonen S, Makkonen M, Kajanoja E, Mannermaa A, Pertti K. Feasibility and acceptance of screening for fragile X mutations in low-risk pregnancies. Eur J Hum Genet 1999;7: 212-6.
29. Snow K, Doud LK, Hagerman R, Pergolizzi RG, Erster SH, Thibodeau SN. Analysis of a CGG sequence at the FMR-1 locus in fragile X families and in the general population. Am J Hum Genet 1993;53:1217-28.
30. Spence WC, Black SH, Fallon L, Maddalena A, Cummings E, Menapace-Drew G, Bick DP. Molecular fragile X screening in normal populations. Am J Med Genet 1996;64:181-3.
31. Tzeng CC, Cho WC, Kuo PL, Chen RM. Pilot fragile X screening in normal population of Taiwan. Diagn Mol Pathol 1999;8:152-6.
32. Verkerk AJMH, Pieretti M, Sutcliffe JS, et al. Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome. Cell 1991;65:905-14.
33. Wang Q, Green E, Bobrow M, Mathew CG. A rapid, nonradioactive screening test for fragile X mutations at the FRAXA and FRAXE loci. J Med Genet 1995;32:170-3.
34. Webb TP, Bundey SE, Thake AI, Todd I. Population incidence and segregation ratios in the Martin-Bell syndrome. Am J Med Genet 1986;23:573-80.